GovCon Bid and Proposal Insights
GovCon Bid and Proposal Insights
Business Transformation Team (BTT)
Podcast Episode: Transforming Health Services – A Deep Dive into the BTT IDIQ Opportunity
In this episode, we unpack the upcoming $150M Business Transformation Team (BTT) IDIQ from the Department of Health and Human Services. With an anticipated RFP release in July 2025, this contract is designed to support large-scale transformation initiatives across HHS.
We’ll explore:
- The mission behind the BTT IDIQ
- Key trends and strategic priorities in federal health transformation
- What industry partners should prepare for (NAICS focus, teaming considerations, and capability alignment)
- How to position your company for success early in the capture lifecycle
Whether you’re a health IT vendor, business consultant, or strategic advisor in the GovCon space, this is one opportunity you don't want to miss.
Listen now and get ahead of the curve.
Contact ProposalHelper at sales@proposalhelper.com to find similar opportunities and help you build a realistic and winning pipeline.
OK, let's untack this. We've received a sources sought notice. This one's from the US Food and Drug Administration, the FDA Right. Think of this as a specific window, maybe, into how a major government agency does its market research before potentially launching a big project.
Speaker 2:Yeah, it's that early stage.
Speaker 1:So our mission for this deep dive is to quickly pull out the most important nuggets of well knowledge and insight from this document. What is the FDA looking for and why?
Speaker 2:And understanding the why is definitely key here. A sources sought notice an SSN. It isn't a contract offer, not at all.
Speaker 1:Right.
Speaker 2:It's issued under FR Part 10, Federal Acquisition Regulation, which actually requires agencies to do market research. Ah, okay so this notice is purely for like information gathering, planning. It lets the FDA gauge what capabilities are out there industry interest before they decide on a strategy.
Speaker 1:Like issuing a formal request later on.
Speaker 2:Exactly, it's them doing their homework, basically making sure they know what's available and, importantly, who can do the work.
Speaker 1:Right, so it's the initial sounding board, and the specific work they're exploring is business transformation, team support services, btt. What is that kind of signal?
Speaker 2:Well, business transformation in a big agency like the FDA usually implies pretty significant change. It could be process re-engineering, maybe integrating new tech, improving, improving how they handle data, maybe even organizational effectiveness stuff. It's not just day-to-day support so bigger picture definitely. It's about helping the agency evolve how it operates yeah and this SSN specifically mentions looking for potential small business sources ah, okay, that's a key detail yeah, capable of providing these BTT services.
Speaker 2:That small business sources Ah, okay, that's a key detail. Yeah, capable of providing these BTT services. That small business angle is explicitly stated.
Speaker 1:And they've attached a draft statement of work in SOW that presumably details the scope of these services.
Speaker 2:Exactly that draft SOW is crucial. It lays out the specific types of support they think they'll need. The goal is to find potential small businesses who can provide the full range of services described in there, and the potential outcome this is all market research for a possible future multiple award, blanket purchase agreement, a BPA.
Speaker 1:A BPA Okay, multiple award, meaning potentially several companies could get a piece of the action.
Speaker 2:That's the idea. Yeah, spreads the capability, maybe the risk too.
Speaker 1:And this potential agreement. It isn't immediate, is it? Or a short term?
Speaker 2:No, not at all. The SSN is very specific. It mentions a potential period of performance spanning from March 29, 2026. To 26. Through March 28, 2031. That's a full five years.
Speaker 1:Wow Five years.
Speaker 2:Yeah, the fact they're thinking about a dedicated transformation team over half a decade. It suggests a pretty significant long-term strategic effort inside the agency.
Speaker 1:It's a marathon, like you said, not a sprint, Definitely. So five years is substantial. If you're a small business out there listening and thinking, hey, we can do that. What exactly does the FDA want you to provide right now?
Speaker 2:They're very clear. The notice asks for three specific things. First, a completed vendor feedback form.
Speaker 1:Okay.
Speaker 2:Second, they want tracked changes or comments on that draft SOW. They actually want your expert take on their proposed scope.
Speaker 1:Makes sense. Get industry feedback.
Speaker 2:Exactly. And third, a capability statement, you know, proving you can actually do the work.
Speaker 1:Got it. Vendor form, sow comments, capability statement and the nuts and bolts. How and when do interested businesses submit these?
Speaker 2:Okay, responses must be sent via email. The address is noahwills at fdahhsgov. Noah Wills. Okay, and this is crucial. The subject line must be exactly precisely sources sought notice FDA SSN 705-40125-Q00064.
Speaker 1:That specific identifier Easy to mess up, so double check that.
Speaker 2:Absolutely vital for them to track and process the responses correctly. Don't get creative with the subject line.
Speaker 1:Tip and the deadline When's it all due?
Speaker 2:Deadline is 12-4-0-0 pm. Eastern Time Sure On Monday, January 27, 2025.
Speaker 1:January 27, 2025.
Speaker 2:Okay, and one practical note they included the contract specialist, Noah Wills, will actually be out of office. No email access from December 28, 2024 through January 12, 2025.
Speaker 1:Ah, good flag. So right over the holiday period into early January.
Speaker 2:Right, so keep that in mind. If you have questions that need an answer during that specific window, might be a delay.
Speaker 1:Okay, so wrapping this up, marc Thiessen yeah, danielle Pletka, what does this all mean for you, the listener? This SSN, it's the FDA doing its homework. Basically, market research under FRR, part 10. Marc Thiessen yeah, danielle Pletka, they're trying to identify potential small businesses that could provide this business transformation team support. It's stage one for a possible future multiple award BPA.
Speaker 2:A big one, potentially spanning five years. Remember, from early 2026 to early 2031.
Speaker 1:Right, so you now know what info the FDA wants that vendor feedback form, your comments on the SOW and your capability statement.
Speaker 2:That's right.
Speaker 1:You know how they want it emailed to Noah Wills using that very specific subject line.
Speaker 2:Very specific.
Speaker 1:And when they need it, by noon Eastern January 27, 2025. And remember that out-of-office period for the contact person.
Speaker 2:And just to reiterate, this is purely market research right now. It is not a guarantee of a contract award down the line. It's them exploring the landscape. Good reminder, which kind of leads to an interesting question for anyone considering responding. You know, given the FDA's unique mission and this five-year timeframe, what specific kinds of business transformation challenges, unique to a regulatory agency like the FDA, would a small business team really need to be ready to tackle? Something to think about?